YU37156B - Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives - Google Patents

Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives

Info

Publication number
YU37156B
YU37156B YU0382/75A YU38275A YU37156B YU 37156 B YU37156 B YU 37156B YU 0382/75 A YU0382/75 A YU 0382/75A YU 38275 A YU38275 A YU 38275A YU 37156 B YU37156 B YU 37156B
Authority
YU
Yugoslavia
Prior art keywords
propylc
yloxy
naphthyl
hydroxy
preparing
Prior art date
Application number
YU0382/75A
Other languages
English (en)
Other versions
YU38275A (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of YU38275A publication Critical patent/YU38275A/xx
Publication of YU37156B publication Critical patent/YU37156B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU0382/75A 1974-02-23 1975-02-18 Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives YU37156B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2408804A DE2408804C2 (de) 1974-02-23 1974-02-23 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten

Publications (2)

Publication Number Publication Date
YU38275A YU38275A (en) 1983-04-27
YU37156B true YU37156B (en) 1984-08-31

Family

ID=5908286

Family Applications (2)

Application Number Title Priority Date Filing Date
YU0382/75A YU37156B (en) 1974-02-23 1975-02-18 Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives
YU1044/81A YU37157B (en) 1974-02-23 1981-04-21 Process for preparing 1-z3-(naphth-1-yloxy)-2-hydroxy-propylc-piperazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU1044/81A YU37157B (en) 1974-02-23 1981-04-21 Process for preparing 1-z3-(naphth-1-yloxy)-2-hydroxy-propylc-piperazine derivatives

Country Status (20)

Country Link
US (1) US3997666A (fr)
JP (1) JPS6029712B2 (fr)
AR (1) AR206339A1 (fr)
AT (1) AT340937B (fr)
BE (1) BE825755A (fr)
CA (1) CA1039282A (fr)
CH (2) CH609342A5 (fr)
DE (1) DE2408804C2 (fr)
DK (1) DK135124C (fr)
ES (1) ES434829A1 (fr)
FI (1) FI59248C (fr)
FR (1) FR2261770B1 (fr)
GB (1) GB1445548A (fr)
IE (1) IE40678B1 (fr)
NL (2) NL175059B (fr)
PL (1) PL92131B1 (fr)
SE (1) SE405601B (fr)
SU (2) SU549085A3 (fr)
YU (2) YU37156B (fr)
ZA (1) ZA751031B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387971A1 (fr) * 1977-04-19 1978-11-17 Delalande Sa Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
US4882330A (en) * 1986-11-21 1989-11-21 A. H. Robins Company, Incorporated 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
EP0269383A3 (fr) * 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-pipérazinyl]-2-butanols utiles pour traiter des manifestations allergiques
DE3918543A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
CA2278660A1 (fr) 1997-01-30 1998-08-06 Kazumi Ogata Derives d'hydroquinone
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
WO2004054560A1 (fr) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Ligand alpha-2-delta pour traiter des symptomes des voies urinaires inferieures
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
NZ543741A (en) 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
ATE412648T1 (de) 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
JP2009504628A (ja) * 2005-08-10 2009-02-05 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
JP2009514851A (ja) 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
JP5483880B2 (ja) * 2006-10-23 2014-05-07 武田薬品工業株式会社 イミノピリジン誘導体およびその用途
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN101671317B (zh) * 2009-10-09 2011-04-27 蚌埠丰原涂山制药有限公司 一种萘哌地尔的制备方法
CN101747293B (zh) * 2009-12-29 2011-12-07 蚌埠丰原涂山制药有限公司 萘哌地尔的制备方法
JP5807423B2 (ja) * 2011-07-21 2015-11-10 大日本印刷株式会社 ナフトピジルの製造方法
CN102816136A (zh) * 2012-09-18 2012-12-12 通化吉通药业有限公司 萘哌地尔制备方法
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
US9272980B2 (en) 2014-06-06 2016-03-01 Ktn Biotec, Inc. Anticancer agent
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Ｐｃｓｋ９阻害剤及びその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
SU549085A3 (ru) 1977-02-28
ZA751031B (en) 1976-02-25
IE40678L (en) 1975-08-23
NL175059C (nl)
YU38275A (en) 1983-04-27
DE2408804C2 (de) 1983-09-22
CH612958A5 (fr) 1979-08-31
JPS6029712B2 (ja) 1985-07-12
IE40678B1 (en) 1979-08-01
YU37157B (en) 1984-08-31
SE7501911L (fr) 1975-08-25
BE825755A (fr) 1975-08-20
FI750449A (fr) 1975-08-24
NL7501877A (nl) 1975-08-26
DK135124B (da) 1977-03-07
ATA132375A (de) 1977-05-15
YU104481A (en) 1983-04-27
DE2408804A1 (de) 1975-09-04
ES434829A1 (es) 1976-12-01
US3997666A (en) 1976-12-14
FR2261770A1 (fr) 1975-09-19
FI59248B (fi) 1981-03-31
FR2261770B1 (fr) 1978-08-04
DK58175A (fr) 1975-10-20
GB1445548A (en) 1976-08-11
AR206339A1 (es) 1976-07-15
CA1039282A (fr) 1978-09-26
FI59248C (fi) 1981-07-10
CH609342A5 (fr) 1979-02-28
NL175059B (nl) 1984-04-16
AT340937B (de) 1978-01-10
DK135124C (da) 1977-08-15
SU561514A3 (ru) 1977-06-05
JPS50121286A (fr) 1975-09-23
SE405601B (sv) 1978-12-18
PL92131B1 (fr) 1977-03-31
AU7826875A (en) 1976-08-19

Similar Documents

Publication Publication Date Title
YU37156B (en) Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives
CS183829B2 (en) Process for preparing thienamycine
HU171059B (hu) Sposob poluchenija piridazinil-benzimidazolov
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU173739B (hu) Sposob poluchenija proizvodnykh tienotiazina
YU39113B (en) Process for preparing 2-arylamino-2-imidazoline derivatives
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
CS189730B2 (en) Process for preparing o-cyanazodyes
HU174348B (hu) Sposob poluchenija proizvodnykh 13-tia-prostaglandinov
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
CS193518B2 (en) Process for preparing moenomycine
CS188259B2 (en) Process for preparing 2-anilinooxazoles
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
YU293975A (en) Process for obtaining phenylpyridylamine derivatives
YU107875A (en) Process for preparing indolinoquinolyzine derivatives
YU39338B (en) Process for preparing indolo-quinolizisdine derivatives
YU157375A (en) Process for preparing new ergopetine derivatives
CS188253B2 (en) Process for preparing 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine
CS188967B2 (en) Process for preparing 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxide
CS191291B2 (en) Process for preparing 3-methylencepham-sulphoxides